학술논문

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.
Document Type
Academic Journal
Source
HIV Medicine (HIV MED), Jul2013; 14(6): 327-336. (10p)
Subject
Language
English
ISSN
1464-2662